| Literature DB >> 15149677 |
Yasuyuki Takeda1, Kouichi Uoto, Michio Iwahana, Takeshi Jimbo, Motoko Nagata, Ryo Atsumi, Chiho Ono, Noriko Tanaka, Hirofumi Terasawa, Tsunehiko Soga.
Abstract
To improve the metabolic stability of 3, which exhibited both in vitro antitumor activity and in vivo efficacy by both iv and po administration, we designed and synthesized new taxane analogues. Most of the synthetic compounds maintained excellent antitumor activity and were scarcely metabolized by human liver microsomes. And some compounds exhibited potent antitumor effects against B16 melanoma BL6 in vivo by both iv and po administration similarly to 3.Entities:
Mesh:
Substances:
Year: 2004 PMID: 15149677 DOI: 10.1016/j.bmcl.2004.03.109
Source DB: PubMed Journal: Bioorg Med Chem Lett ISSN: 0960-894X Impact factor: 2.823